Service

E-Prescribing and EPCS Certification Readiness

EPCS certification is the third-party audit or certification that the DEA requires, under 21 CFR § 1311.300, before an electronic prescribing or pharmacy application can be used for controlled substance prescriptions; DirectTrust runs a DEA-approved certification program for it, alongside a separate E-Prescribing Network accreditation. Both apply to electronic prescribing networks and to prescribing or pharmacy software vendors. Integral Healthcare Solutions (IHS) drafts your organizational procedures and evidence for e-prescribing accreditation and certification; your engineers own technical conformance.

What is EPCS certification and e-prescribing accreditation?

Two sets of text govern this work.

The DEA rule: 21 CFR Part 1311

Under 21 CFR § 1311.300(a) (eCFR text as of September 1, 2026), “the application provider of an electronic prescription application or a pharmacy application must have a third-party audit of the application that determines that the application meets the requirements of this part”. The audit is required “(1) Before the application may be used to create, sign, transmit, or process controlled substance prescriptions. (2) Whenever a functionality related to controlled substance prescription requirements is altered or every two years, whichever occurs first.”

Section 1311.300(e) allows a certification in place of the audit: “If a certifying organization whose certification process has been approved by DEA verifies and certifies that an electronic prescription or pharmacy application meets the requirements of this part, certification by that organization may be used as an alternative to the audit requirements”. Section 1311.300(f) adds a disclosure duty: “The application provider must make the audit or certification report available to any practitioner or pharmacy that uses the application or is considering use of the application.”

The DirectTrust programs: 2026 criteria

DirectTrust's January 5, 2026 criteria release, published on financialcontent.com, names three programs for this work: E-Prescribing Network v10.1, Electronic Prescriptions for Controlled Substances Certification Program for Pharmacy Vendors v4.6, and Electronic Prescriptions for Controlled Substances Certification Program for Prescribing Vendors v4.6. The E-Prescribing Network version carries an asterisk, the release's marker for programs that include DirectTrust's own baseline privacy and security criteria. The release also places DirectTrust's programs under EHNAC, its Electronic Healthcare Network Accreditation Commission.

DirectTrust's e-prescribing program page presents its programs as a check of e-prescribing transactions against both the standards the industry uses and the rules regulators impose (DirectTrust, e-Prescribing, opened October 3, 2026, accreditation.directtrust.org/programs/e-prescribing). The same page reports that DEA has approved four organizations as certifiers under this program, DirectTrust among them. DirectTrust issues its criteria on request rather than publishing them (DirectTrust, Programs, opened October 3, 2026, accreditation.directtrust.org/programs/programs-overview).

Who needs it and what triggers it

DirectTrust's accreditation process runs on a 2-year cycle. The applicant signs and submits an Accreditation Program Agreement and a Financial Attestation of revenue, completes a self-assessment, and waits for the Commission to vote on the Accreditation Report (DirectTrust, The Accreditation Process, opened October 3, 2026, accreditation.directtrust.org/about/accreditation-process). Confirm with DirectTrust how each step applies to the EPCS certification programs you choose.

How IHS helps

IHS works on the organizational procedures and evidence that sit around the software. The work runs in this order:

  1. A gap assessment of your organizational procedures against the DirectTrust criteria you request and obtain.
  2. Questionnaires on releases, access governance and incidents.
  3. A requirement ownership map that ties each criterion and each § 1311.300 obligation to an owner.
  4. Drafting: release and change documentation procedures (including how a change to controlled-substance functionality is flagged for a new audit or certification), access governance and incident procedures, and the evidence file.
  5. A mock review against the criteria, and drafted responses to findings for your team to finalize.

You supply the criteria, product documentation, security records, and your software, pharmacy and legal specialists. You engage your own auditor or certifier.

The limit: technical conformance, and the EPCS audit or certification itself, belong to your engineers and your auditor or certifier. IHS is not an auditor or a certifying organization and does not test your application.

What to have ready

Each item ties to 21 CFR § 1311.300 (eCFR, September 1, 2026) or to DirectTrust's 2026 criteria, process and application pages (DirectTrust, The Accreditation Process, opened October 3, 2026, accreditation.directtrust.org/about/accreditation-process, and DirectTrust, Apply, opened October 3, 2026, accreditation.directtrust.org/apply).

Printable version of this checklist (PDF)

How it compares

RouteWhat the source saysSource
Third-party auditThe audit may be done by “(1) A person qualified to conduct a SysTrust, WebTrust, or SAS 70 audit. (2) A Certified Information System Auditor who performs compliance audits as a regular ongoing business activity.”21 CFR § 1311.300(b)
DEA-approved certificationCertification by an organization whose process DEA has approved “may be used as an alternative to the audit requirements”. DirectTrust reports that it is one of four certifiers DEA has approved.§ 1311.300(e), (DirectTrust, e-Prescribing, opened October 3, 2026, accreditation.directtrust.org/programs/e-prescribing)
DirectTrust E-Prescribing Network accreditationAccreditation of an e-prescribing network, judged on how its transactions measure up to industry standards and to regulators' rules. It is separate from the DEA audit or certification.(DirectTrust, e-Prescribing, opened October 3, 2026, accreditation.directtrust.org/programs/e-prescribing)

Your auditor or certifier, your customers' contracts and your counsel set which route fits.

What it costs

DirectTrust's application page carries its fee schedule, and fees depend on program, location count and revenue level (DirectTrust, Apply, opened October 3, 2026, accreditation.directtrust.org/apply). The program-specific EPCS line lists a $3,500 annual fee, a $1,750 multi-program fee and a $4,000 assessment fee, and the multi-program rate is available only when the second program is also an EPCS program. In the revenue-tiered schedule, the Very Small tier (under $3M revenue) is listed at a $3,100 annual fee and $5,500 assessment fee, and the Very Large tier (over $75M) at $27,500 and $15,000. Travel for location reviews is billed separately afterward, and each additional documentation submission is billed at $250 per hour of assessor time. Verify current fees with DirectTrust.

IHS scopes each engagement after a free introductory call.

For the full DirectTrust fee schedule by revenue tier, with worked examples for more than one program or location, see IHS's DirectTrust accreditation fees page.

What this is not

Frequently asked questions

What is EPCS certification and who needs it?

Under 21 CFR 1311.300, the provider of an electronic prescription application or a pharmacy application must have a third-party audit showing the application meets DEA's Part 1311 requirements before it is used for controlled substance prescriptions. A certification by a DEA-approved certifying organization may be used instead of the audit. It applies to prescribing and pharmacy software vendors whose products handle controlled substance prescriptions.

Does DEA require a third-party audit or certification for e-prescribing software?

Yes, for applications used to create, sign, transmit, or process controlled substance prescriptions. Section 1311.300(a) requires the third-party audit, and section 1311.300(e) allows certification by a DEA-approved certifying organization as an alternative.

Who can perform the EPCS audit?

Section 1311.300(b) names a person qualified to conduct a SysTrust, WebTrust, or SAS 70 audit, or a Certified Information System Auditor who performs compliance audits as a regular ongoing business activity. A DEA-approved certifying organization can certify the application instead. DirectTrust reports that it is one of four certifiers DEA has approved.

How often must an EPCS application be re-audited or re-certified?

Section 1311.300(a)(2) requires a new audit whenever a functionality related to controlled substance prescription requirements is altered, or every two years, whichever occurs first.

What is DirectTrust E-Prescribing Network accreditation and how does it differ from EPCS certification?

E-Prescribing Network v10.1 is a DirectTrust accreditation that judges how an organization's e-prescribing transactions measure up to industry standards and to regulators' rules, and it includes DirectTrust's baseline privacy and security criteria. EPCS certification is a separate DirectTrust program, at v4.6 for prescribing vendors and for pharmacy vendors, tied to the DEA requirement in 21 CFR 1311.300.

How much does DirectTrust EPCS certification cost?

DirectTrust's application page lists EPCS at $3,500 annual, $1,750 multi-program and $4,000 assessment, and notes that EPCS can only be a multiple program with another EPCS program. Travel for location reviews is invoiced separately, and additional documentation submissions are charged at $250 per hour of assessor time. Verify current fees with DirectTrust.

Must we share our EPCS audit report with prescribers and pharmacies?

Yes. Section 1311.300(f) states that the application provider must make the audit or certification report available to any practitioner or pharmacy that uses the application or is considering use of the application.

What triggers a new EPCS audit when we change our software?

Any alteration to a functionality related to controlled substance prescription requirements triggers a new audit or certification under section 1311.300(a)(2). IHS drafts the release and change documentation procedure that flags those changes so your team can act on them.

EPCS certification for prescribing vs pharmacy applications: what is different?

Section 1311.300 applies to both electronic prescription applications and pharmacy applications. DirectTrust runs them as two programs, the EPCS Certification Program for Prescribing Vendors v4.6 and for Pharmacy Vendors v4.6. The criteria for each are released on request, so the differences are read from the criteria your organization obtains.

Recent changes

  • ONC and CMS Launch Industry Electronic Prior Authorization Testing Initiative

    · Assistant Secretary for Technology Policy / Office of the National Coordinator for Health IT

    Assistant Secretary for Technology Policy / Office of the National Coordinator for Health IT states: “Payers, providers, EHR developers and intermediaries invited are to test prior authorization workflows together ahead of 2027 requirements The Office of the National Coordinator for Health IT (ONC) at the U.S. Department of Health and Human Services (HHS), in partnership with the Centers for Medicare & Medicaid Services (CMS), announced a series of industry testing events in production-like environments to advance end-to-end electronic prior authorization (ePA).”

    Checked

  • Health Data, Technology, and Interoperability: ONC Deregulatory Actions To Unleash Prosperity

    · U.S. Department of Health and Human Services (Office of the Secretary)

    Full title: Health Data, Technology, and Interoperability: ONC Deregulatory Actions To Unleash Prosperity (Final rule; FR Doc. 2026-21943)

    U.S. Department of Health and Human Services (Office of the Secretary) states: “This final rule focuses on deregulatory actions identified in HHS regulations regarding health information technology standards, implementation specifications, and certification criteria and regarding certification programs for health information technology.”

    Checked

  • HHS Finalizes HTI-5 Deregulatory Rule to Encourage Innovation and Reduce Health IT Certification Program Compliance Costs

    · Assistant Secretary for Technology Policy / Office of the National Coordinator for Health IT

    Assistant Secretary for Technology Policy / Office of the National Coordinator for Health IT states: “This final rule aligns with President Trump's Executive Order (EO) 14192, Unleashing Prosperity through Deregulation , and EO 14267, Reducing Anti-Competitive Regulatory Barriers , and is projected to save more than $1.5 billion in regulatory costs. The HTI-5 Final Rule significantly reduces administrative burdens for health IT developers participating in the ONC Health IT Certification Program (Certification Program).”

    Checked

  • CMS Proposes Reforms to Strengthen Transparency & Affordability in Medicare Advantage and Part D

    · Centers for Medicare & Medicaid Services

    Centers for Medicare & Medicaid Services states: “CMS issued a proposed rule that would improve the accuracy of provider directories for Medicare Advantage plans, establish transparency and compensation requirements for Pharmacy Benefit Managers, and deliver enhanced cost-saving protections for low-income Medicare beneficiaries.”

    Checked

  • Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026

    · Centers for Medicare & Medicaid Services

    Full title: Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026 (Proposed rule; FR Doc. 2026-21420)

    Centers for Medicare & Medicaid Services states: “This proposed rule would implement section 6219 (Adjustments to Medicare Part D Cost-Sharing Reductions for Low-Income Individuals), section 6220 (Requiring Enhanced and Accurate Lists of (REAL) Health Providers Act), and section 6224 (Modernizing and Ensuring Pharmacy Benefit Manager Accountability) of the Consolidated Appropriations Act, 2026.”

    Checked

More: ONC / ASTP · Pharmacy operations · Health IT and interoperability · all standards changes

Talk with IHS's CEO

A 30-minute introductory meeting with Thomas G. Goddard, JD, PhD, to scope what your organization needs.

Schedule a Free Discovery Session